RNS

DGAP-News: JPMorgan ETFs (Ireland) ICAV: Dividend Declaration

Thursday, May 6, 2021 - 5:04pm

b'This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n06.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.\nThe issuer is solely responsible for the content of this announcement.\nThe DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\n'

JPMorgan ETFs (Ireland) ICAV Announces Dividend Declaration

Thursday, May 6, 2021 - 5:00pm

b'This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n'

DGAP-News: BP p.l.c.: Director/PDMR Shareholding

Tuesday, May 4, 2021 - 1:09pm

b'This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.\nThis information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.\nThis information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n04.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.\nThe issuer is solely responsible for the content of this announcement.\nThe DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\n'

DGAP-News: Swedish Electromagnet Invest AB (Publ) : Annual Financial Report

Friday, April 30, 2021 - 6:52pm

b'The issuer is solely responsible for the content of this announcement.\nThis information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'The issuer is solely responsible for the content of this announcement.\nThis information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n30.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.\nThe issuer is solely responsible for the content of this announcement.\nThe DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\n'

DGAP-News: JPMorgan ETFs (Ireland) ICAV: Publication of Audited Annual Report

Friday, April 30, 2021 - 6:50pm

b'This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n30.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.\nThe issuer is solely responsible for the content of this announcement.\nThe DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\n'

JPMorgan ETFs (Ireland) ICAV: Annual Financial Report

Friday, April 30, 2021 - 5:00pm

b'This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n'

DGAP-News: BP p.l.c.: Director/PDMR Shareholding

Thursday, April 29, 2021 - 12:49am

b'This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.\nThis information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • b'This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.\nThis information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .\n28.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.\nThe issuer is solely responsible for the content of this announcement.\nThe DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\n'

NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsy

Monday, August 31, 2020 - 12:30pm

The funds will be used to accelerate commercial growth and to pursue expanded indications for the RNS System, the companys innovative technology for refractory focal epilepsy.

Key Points: 
  • The funds will be used to accelerate commercial growth and to pursue expanded indications for the RNS System, the companys innovative technology for refractory focal epilepsy.
  • This round of financing will enable us to execute our commercial strategy and maximize therapy adoption at comprehensive epilepsy centers, said Mike Favet, CEO of NeuroPace.
  • With this additional funding, we can bring RNS Systems life-changing technology to significantly more people who are living with refractory epilepsy.
  • The companys first product, the RNS System, is the only FDA-approved brain-responsive neurostimulator for the treatment of focal onset refractory epilepsy.

CORRECTION: Managers' transactions 6

Tuesday, May 5, 2020 - 3:00pm

This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .

CORRECTION: Managers' transactions 7

Tuesday, May 5, 2020 - 3:00pm

This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact rns@lseg.com or visit www.rns.com .